Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Contrast Media × Thoracic × Clear all

Phase

Status

Recruiting 3 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Dermatologic 1 CNS 1

Conditions

Melanoma 1 Lung Neoplasms 1

Interventions

Carboplatin 59 Cisplatin 40 Pemetrexed 36 Drug Therapy 35 osimertinib 23 anlotinib 19 Etoposide 19 Paclitaxel 18 Surgical Procedures, Operative 17 tislelizumab 16 pembrolizumab 15 toripalimab 14 Radiotherapy 14 130-nm albumin-bound paclitaxel 14 aflutinib 12 Docetaxel 11 Bevacizumab 11 sintilimab 10 Injections 10 durvalumab 9 Specimen Handling 9 Platinum 8 Magnetic Resonance Spectroscopy 8 Immunotherapy 8 cemiplimab 7 atezolizumab 7 Radiosurgery 7 Platinum Compounds 7 PM 01183 7 lorlatinib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492121 2026-03-25

GAPIMET

University of Zurich

Phase 2 Not yet recruiting

DermatologicThoracic

Lung Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡